The Pulse Egypt › Reme-D
HealthTech Active

Reme-D

Develops and manufactures affordable, heat-tolerant molecular diagnostic tests for TB, HIV, hepatitis and HPV, aimed at African markets.

HeadquartersCairo, Egypt
Founded2023
StageSeed
Funding raised$1.9M
Funding history

Rounds

  • $500k · Grant/investment · 2026 Global Innovation Fund Source
  • $1.4M · Pre-Series A · 2026 Anara Impact Capital (lead), Global Innovation Fund, Africa Health Ventures Source
Team

Founders

  • Salma Tammam
    Salma Tammam Founder & CEO

    Salma Tammam is an Egyptian nanoscientist who founded Reme-D in 2023 and is a 2026 Cartier Women's Initiative fellow.

Other HealthTech founders →

Profile compiled from the public sources listed above, last updated 2026-11-19. Founders can claim and complete this profile through the update form.